Regarding the expression levels of CD68 as a M1-TAM marker in carcinomas and prognosis, it has been reported that the low expression of CD68 and CD163 in classical Hodgkin lymphoma indicates a better prognosis [63]. This evidence concerns the gene CD163 and carcinoma.